Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD: Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf. 2010, 33: 171-187. 10.2165/11319380-000000000-00000
Article
CAS
PubMed
Google Scholar
Schneck DW, Knopp RH, Ballantyne CM, McPherson R, Chitra RR, Simonson SG: Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol. 2003, 91: 33-41.
Article
CAS
PubMed
Google Scholar
Kostapanos MS, Milionis HJ, Elisaf MS: An overview of the extra-lipid effects of rosuvastatin. J Cardiovasc Pharmacol Ther. 2008, 13: 157-174. 10.1177/1074248408318628
Article
CAS
PubMed
Google Scholar
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006, 295: 1556-1565. 10.1001/jama.295.13.jpc60002
Article
CAS
PubMed
Google Scholar
Furberg CD: Natural statins and stroke risk. Circulation. 1999, 99: 185-188. 10.1161/01.CIR.99.2.185
Article
CAS
PubMed
Google Scholar
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008, 359: 2195-2207. 10.1056/NEJMoa0807646
Article
CAS
PubMed
Google Scholar
Viasus D, Garcia-Vidal C, Gudiol F, Carratala J: Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis. 2010, 29: 143-152. 10.1007/s10096-009-0835-0
Article
CAS
PubMed
Google Scholar
Bielinska A, Gluszko P: Statins–are they potentially useful in rheumatology?. Pol Arch Med Wewn. 2007, 117: 420-425.
PubMed
Google Scholar
Undas A, Brummel-Ziedins KE, Mann KG: Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005, 25: 287-294.
Article
CAS
PubMed
Google Scholar
Novack V, Eisinger M, Frenkel A, Terblanche M, Adhikari NK, Douvdevani A, Amichay D, Almog Y: The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial. Intensive Care Med. 2009, 35: 1255-1260. 10.1007/s00134-009-1429-0
Article
CAS
PubMed
Google Scholar
Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005, 45: 89-118. 10.1146/annurev.pharmtox.45.120403.095748
Article
CAS
PubMed
PubMed Central
Google Scholar
Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis. 2007, 7: 358-368. 10.1016/S1473-3099(07)70111-1
Article
CAS
PubMed
Google Scholar
Merx MW, Liehn EA, Janssens U, Lutticken R, Schrader J, Hanrath P, Weber C: HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation. 2004, 109: 2560-2565. 10.1161/01.CIR.0000129774.09737.5B
Article
CAS
PubMed
Google Scholar
Merx MW, Liehn EA, Graf J, van de Sandt A, Schaltenbrand M, Schrader J, Hanrath P, Weber C: Statin treatment after onset of sepsis in a murine model improves survival. Circulation. 2005, 112: 117-124. 10.1161/CIRCULATIONAHA.104.502195
Article
CAS
PubMed
Google Scholar
Chaudhry MZ, Wang JH, Blankson S, Redmond HP: Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. Surg Infect (Larchmt). 2008, 9: 183-194. 10.1089/sur.2006.077.
Article
Google Scholar
Souza Neto JL, Araujo Filho I, Rego AC, Dominici VA, Azevedo IM, Egito ES, Brandao-Neto J, Medeiros AC: Effects of simvastatin in abdominal sepsis in rats. Acta Cir Bras. 2006, 21 (Suppl 4): 8-12.
Article
PubMed
Google Scholar
Chen CH, Lee RP, Wu WT, Liao KW, Hsu N, Hsu BG: Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats. Resuscitation. 2007, 74: 166-174. 10.1016/j.resuscitation.2006.12.002
Article
CAS
PubMed
Google Scholar
Hackam DG, Mamdani M, Li P, Redelmeier DA: Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006, 367: 413-418. 10.1016/S0140-6736(06)68041-0
Article
CAS
PubMed
Google Scholar
Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004, 110: 880-885. 10.1161/01.CIR.0000138932.17956.F1
Article
CAS
PubMed
Google Scholar
Liappis AP, Kan VL, Rochester CG, Simon GL: The effect of statins on mortality in patients with bacteremia. Clin Infect Dis. 2001, 33: 1352-1357. 10.1086/323334
Article
CAS
PubMed
Google Scholar
Thomsen RW, Hundborg HH, Johnsen SP, Pedersen L, Sorensen HT, Schonheyder HC, Lervang HH: Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med. 2006, 34: 1080-1086. 10.1097/01.CCM.0000207345.92928.E4
Article
CAS
PubMed
Google Scholar
Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G: Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006, 32: 75-79. 10.1007/s00134-005-2859-y
Article
PubMed
Google Scholar
Sun HY, Singh N: Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients. Clin Infect Dis. 2009, 48: 745-755. 10.1086/597039
Article
PubMed
Google Scholar
Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T: Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med. 2009, 169: 1658-1667. 10.1001/archinternmed.2009.286
Article
PubMed
Google Scholar
Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. M100-S20. 2010, Available from: [http://www.clsi.org/source/orders/free/m100-s20.pdf]. Accessed 14 September 2011. 2010, Villanova, PA, Available from:. Accessed 14 September 2011. 2010
Google Scholar
CLSI: Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard. 2009, Available from [http://www.clsi.org/source/orders/free/m07-a8.pdf]. Accessed 14 September 2011. 2009, Villanova, PA, Eighth, Available from. Accessed 14 September 2011. 2009
Google Scholar
Jerwood S, Cohen J: Unexpected antimicrobial effect of statins. J Antimicrob Chemother. 2008, 61: 362-364.
Article
CAS
PubMed
Google Scholar
Welsh AM, Kruger P, Faoagali J: Antimicrobial action of atorvastatin and rosuvastatin. Pathology. 2009, 41: 689-691. 10.3109/00313020903305860
Article
CAS
PubMed
Google Scholar
Bergman P, Linde C, Putsep K, Pohanka A, Normark S, Henriques-Normark B, Andersson J, Bjorkhem-Bergman L: Studies on the antibacterial effects of statins–in vitro and in vivo. PLoS One. 2011, 6: e24394- 10.1371/journal.pone.0024394
Article
CAS
PubMed
PubMed Central
Google Scholar
Bjorkhem-Bergman L, Lindh JD, Bergman P: What is a relevant statin concentration in cell experiments claiming pleiotropic effects?. Br J Clin Pharmacol. 2011, 72: 164-165. 10.1111/j.1365-2125.2011.03907.x
Article
PubMed
PubMed Central
Google Scholar
Yamazaki H, Suzuki M, Aoki T, Morikawa S, Maejima T, Sato F, Sawanobori K, Kitahara M, Kodama T, Saito Y: Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. J Atheroscler Thromb. 2006, 13: 295-307. 10.5551/jat.13.295
Article
CAS
PubMed
Google Scholar
Muck AO, Seeger H, Wallwiener D: Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. Z Kardiol. 2004, 93: 398-402. 10.1007/s00392-004-0081-5
Article
CAS
PubMed
Google Scholar
Tapia-Perez JH, Kirches E, Mawrin C, Firsching R, Schneider T: Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells. Cancer Chemother Pharmacol. 2011, 67: 1193-1201. 10.1007/s00280-010-1535-2
Article
CAS
PubMed
Google Scholar
Friesen JA, Rodwell VW: The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol. 2004, 5: 248- 10.1186/gb-2004-5-11-248
Article
PubMed
PubMed Central
Google Scholar
Tesfamariam B, Frohlich BH, Gregg RE: Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity. J Cardiovasc Pharmacol. 1999, 34: 95-101. 10.1097/00005344-199907000-00016
Article
CAS
PubMed
Google Scholar
Ishikawa M, Okajima F, Inoue N, Motomura K, Kato T, Takahashi A, Oikawa S, Yamada N, Shimano H: Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. J Atheroscler Thromb. 2006, 13: 329-335. 10.5551/jat.13.329
Article
CAS
PubMed
Google Scholar